Concomitant use of divalproex sodium and lamotrigine in developmentally disabled patients with epilepsy: a retrospective evaluation of efficacy and tolerability

Hayashi, 2001, Epilepsy in patients with severe motor and intellectual disabilities: a long-term follow-up, Brain Dev., 33, 416 Mattson, 1996, The role of the old and the new antiepileptic drugs in special populations: mental and multiple handicaps, Epilepsia, 37, S45, 10.1111/j.1528-1157.1996.tb06039.x Steffenburg, 1998, Intractable epilepsy in a population-based series of mentally retarded children, Epilepsia, 39, 767, 10.1111/j.1528-1157.1998.tb01163.x Sunder, 1997, Meeting the challenge of epilepsy in persons with multiple handicaps, J. Child Neurol., 12, S38, 10.1177/0883073897012001091 Pellock, 1996, A decade of modern epilepsy therapy in institutionalized mentally retarded patients, Epilepsy Res., 25, 263, 10.1016/S0920-1211(96)00072-1 Friis, 1998, Valproate in the treatment of epilepsy in people with intellectual disability, J. Intellect. Disabil. Res., 42, 32 Dulac, 1997, Use of lamotrigine in Lennox–Gastaut and related epilepsy syndromes, J. Child Neurol., 12, S23, 10.1177/0883073897012001071 Motte, 1997, Lamotrigine for generalized seizures associated with Lennox–Gastaut syndrome, N. Engl. J. Med., 337, 1807, 10.1056/NEJM199712183372504 Bhaumik, 1997, A naturalistic study of the use of vigabatrin, lamotrigine and gabapentin in adults with learning disabilities, Seizure, 6, 127, 10.1016/S1059-1311(97)80066-0 Coppola, 1997, Lamotrigine as add-on drug in children and adolescents with refractory epilepsy and mental delay: an open trial, Brain Dev., 19, 398, 10.1016/S0387-7604(97)00046-6 King, 1996, Efficacy of lamotrigine in the developmentally disabled, Epilepsia, 37, 162 McKee, 1998, Effects of lamotrigine adjunctive therapy in mentally retarded patients with epilepsy: an interim analysis, Epilepsia, 39, 130 Sorensen, 1998, Long-term follow-up on lamotrigine in treatment of epilepsy in the mentally retarded, Epilepsia, 39, 130 Uvebrant, 1994, Intractable epilepsy in children: the efficacy of lamotrigine treatment, including non-seizure related benefits, Neuropediatrics, 25, 284, 10.1055/s-2008-1073041 Brodie, 1997, Lamotrigine substitution study: evidence for synergism with sodium valproate, Epilepsy Res., 26, 423, 10.1016/S0920-1211(96)01007-8 Ferrie, 1994, Therapeutic interaction of lamotrigine and sodium valproate in intractable myoclonic epilepsy, Seizure, 3, 157, 10.1016/S1059-1311(05)80208-0 Pisani, 1999, The efficacy of valproate–lamotrigine comedication in refractory complex partial seizures: evidence for a pharmacodynamic interaction, Epilepsia, 40, 1141, 10.1111/j.1528-1157.1999.tb00832.x Privitera, 1998, Lamotrigine combined with valproate for idiopathic generalized epilepsy, Epilepsia, 39, 52 Giannakodimos, 1999, Usefulness of lamotrigine and valproate in patients with IGE, Epilepsia, 40, 253 Michel, 1998, Intractable epilepsy in mentally handicapped patients: valproic acid and lamotrigine combination improves seizure control and quality of life, Epilepsia, 39, 127 Jozwiak, 2000, Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in patients with carbamazepine- or valproate-resistant epilepsy, Seizure, 9, 486, 10.1053/seiz.2000.0444 Gates, 1999, Efficacy of valproate and lamotrigine therapy in patients with medically intractable epilepsy, Epilepsia, 40, 143 McCabe, 2001, Effect of divalproex–lamotrigine combination therapy in frontal lobe seizures, Arch. Neurol., 58, 1264, 10.1001/archneur.58.8.1264 Kanner, 2000, Adding valproate to lamotrigine: a study of their pharmacokinetic interaction, Neurology, 55, 588, 10.1212/WNL.55.4.588 Gidal, 2001, Lamotrigine pharmacokinetics in the presence of low dose VPA and during conversion to monotherapy, Epilepsia, 42, 89 Gidal, 2000, Lack of an effect of valproate concentration on lamotrigine pharmacokinetics in developmentally disabled patients with epilepsy, Epilepsy Res., 42, 23, 10.1016/S0920-1211(00)00160-1 Morris, 2000, Clinical study of lamotrigine and valproic acid in patients with epilepsy: using a drug interaction to advantage, Ther. Drug Monitor., 22, 656, 10.1097/00007691-200012000-00003 Beran, 1998, Aggressive behavior in intellectually challenged patients with epilepsy treated with lamotrigine, Epilepsia, 39, 280, 10.1111/j.1528-1157.1998.tb01373.x Faught, 1999, Adding lamotrigine to valproate: incidence of rash and other adverse effects. Post marketing Antiepileptic Drug Survey (PADS) Group, Epilepsia, 40, 1135, 10.1111/j.1528-1157.1999.tb00831.x Guberman, 1999, Lamotrigine associated rash: risk/benefit considerations in adults and children, Epilepsia, 40, 985, 10.1111/j.1528-1157.1999.tb00807.x McCabe, 1998, Clinical efficacy of combination therapy with valproic acid and lamotrigine in intractable epilepsy: high success rate with low incidence of rash, Epilepsia, 39, 49 Richens, 1995, Safety of lamotrigine, Epilepsia, 35, 37, 10.1111/j.1528-1157.1994.tb05965.x